5 reasons to choose LSX Nordic

LSX Nordic focusses almost exclusively on 3 main profiles – Biotech, Medtech and Healthtech CEOs, investors, and large pharma and medtech companies. That means our delegation is extremely focussed, extremely relevant and perfectly matched for partnering and investment.

LSX Nordic offers access to more qualified life science investors than any event in the region. In 2023 will be bringing over 150 of the world’s most active investors to Copenhagen. Fundraising? There’s no better place to be.


LSX Nordic has a highly sophisticated, easy to use and widely adopted 1-2-1 partnering platform. All our attendees are highly qualified and available to contact via a huge range of search criteria. Other events say they do ‘partnering’. We’re the experts at it.


LSX has a 9 year track record of building communities and running events across the world. We have an unrivalled global network of CEOs, investors and pharma and we’ve been bringing the very best of them to the Nordic region for the last 6 years.


As well as partnering, content, showcases and exhibition, LSX Nordic offers a range of smaller group meetings/CEO forums/workshops targeting particular profiles of attendees. This means highly qualified groups of attendees to meet in an interactive and intimate setting and provides you with the opportunity to talk to the people that matter most to you.